secwatch.observer — SEC 8-K summary
======================================

Issuer:     OptimizeRx Corp (OPRX)
CIK:        0001448431
Form:       8-K
Filed at:   2021-12-22T23:59:59+00:00
Accession:  0001213900-21-067049
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OptimizeRx President & CSO Miriam Paramore to retire, transition to advisor role
--------------------------------------------------------------------------------

- Paramore retires as President & CSO effective Dec 31, 2021; will advise through July 31, 2022.
- Her option grants continue vesting during advisory term; she receives full 2021 cash bonus.
- Ed Stelmakh joined as CFO/COO; new exec team includes Febbo, Stelmakh, Silvestro, Inman, Odence-Ford.
- Company cites 45% 3-year CAGR and ~$1B market cap; succession planned, functions transitioned.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1448431/000121390021067049/0001213900-21-067049-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1448431/000121390021067049/ea152841-8k_optimizerx.htm
  HTML page:      https://secwatch.observer/filing/0001213900-21-067049

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer